Delivery Order SPE2DB24D2010-SPE2DB24FZVF2
Award Date
6/13/24
Potential Completion Date
7/8/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 200-unit vials of Botox to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $23,285.20. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $58,213 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024, with a period of performance through October 16, 2024. The contract is a Delivery Order placed against an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
This federal contract award is for the delivery of BOTOX 200 unit vials to the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $23,285.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis with a ceiling value of $11,642.60. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which has a maximum value of $999,999,999.00 and...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, with an ultimate completion date of December 4, 2024. The contract was not set aside for any specific business category....
This federal contract award is for the delivery of Botox 200 unit vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,463.90 and is a firm fixed-price delivery order. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $6,985.56. The contract has a firm fixed price pricing type and a completion date of July 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award is for the supply of BOTOX 100 UNIT VIALS, with a ceiling value of $10,336.32. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...